(Q48289068)

English

Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Janus TJ

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Kim EE

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Tilbury R

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Bruner JM

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Yung WK

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

publication date

1 May 1993

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

33

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

540-548

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410330520

21 January 2018

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

https://api.crossref.org/works/10.1002%2FANA.410330520

21 January 2018

Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FANA.410330520

21 January 2018

Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410330520

21 January 2018

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410330520

21 January 2018

Identifiers

10.1002/ANA.410330520

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/8498831

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48289068&oldid=2194109418"